Abstract
Intestinal microbiota (IM) plays a key role in colonic fermentation of oligosaccharides, in immunity modulation and in protection against conventionally pathogenic microorganisms. Colonization of gastrointestinal tract in newborns starts with participation of the mother’s vaginal flora and continuous due to breast feeding by means of breast milk oligosaccharides. Both bifidobacteria and lactobacilli are the most common representatives of IM with a number of physiologic effects. The new combined probiotic contains B. breve BR-03 and L. rhamnosus GG strains. Indications and other clinical aspects are discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
